VAERS reports by lot

Pfizer Pneumococcal lot FJ2602: VAERS reports

54 VAERS reports list lot FJ2602 as a Pfizer Pneumococcal vaccine, received between 2022-02-11 and 2024-03-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
54
Reports
4%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction10253%
Dermatological (non-injection-site)2412%
General / Systemic (non-local)2111%
Allergic / Anaphylactic116%
Neurological105%
Musculoskeletal95%
Cardiac / Cardiovascular63%
Gastrointestinal53%
Psychiatric / Neuropsychiatric42%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida9
Texas8
Maryland3
Virginia3
New Jersey3
Michigan2
Colorado2
Wisconsin2
South Carolina2
North Carolina2
Georgia2
Missouri1

Reports by month received

2022-021
2022-034
2022-046
2022-057
2022-069
2022-078
2022-084
2022-094
2022-105
2022-112
2022-121
2023-041
2023-091
2024-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.